https://www.has-sante.fr/jcms/p_3576306/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre 2025 false false false France evaluation of the transparency committee olaparib cancer Imfinzi endometrial neoplasms durvalumab Lynparza endometrium neoplasm, malignant olaparib association olaparib durvalumab Endomet
--- https://www.has-sante.fr/jcms/p_3506840/fr/imfinzi-durvalumab-cancer-bronchique-non-a-petites-cellules 2024 false false false France evaluation of the transparency committee Imfinzi Durvalumab durvalumab durvalumab
--- https://pgtmsite.files.wordpress.com/2024/01/mic_-durvalumab_ce-1.pdf 2021 false false false Canada evaluation of the transparency committee body weight methyl isocyanate durvalumab durvalumab Imfinzi microbial sensitivity tests hospitals, proprietary
--- https://pgtmsite.files.wordpress.com/2024/01/re_durvalumab_strategie-posologique_final4.pdf 2021 Canada drug information albumin/globulin ratio What Month is it Ratio durvalumab Strategy Regulatory Report durvalumab research report Durvalumab
Currated CISMeF NLP mapping